Supernus Pharmaceuticals (S49.STU) Q2 2026 Earnings

5MayConfirmed
Q1 2026
Q2 2026
0.25
0.41
0.56
0.72

Details

Expected EPS
0.253883525
Actual EPS
0.51359655709
Surprise EPS
0.26
Surprise Percent
+102.3%

Description

Supernus Pharmaceuticals (S49.STU) has reported earnings of 0.51359655709 per share for Q2 2026.

0 Comments

Share your thoughts